22-23575030-AC-ACC
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_020070.4(IGLL1):c.258dupG(p.Phe87ValfsTer6) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,860 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_020070.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGLL1 | NM_020070.4 | c.258dupG | p.Phe87ValfsTer6 | frameshift_variant | Exon 2 of 3 | ENST00000330377.3 | NP_064455.1 | |
IGLL1 | NM_001369906.1 | c.261dupG | p.Phe88ValfsTer6 | frameshift_variant | Exon 2 of 3 | NP_001356835.1 | ||
IGLL1 | NM_152855.3 | c.207-1446dupG | intron_variant | Intron 1 of 1 | NP_690594.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGLL1 | ENST00000330377.3 | c.258dupG | p.Phe87ValfsTer6 | frameshift_variant | Exon 2 of 3 | 1 | NM_020070.4 | ENSP00000329312.2 | ||
IGLL1 | ENST00000249053.3 | c.207-1446dupG | intron_variant | Intron 1 of 1 | 1 | ENSP00000249053.3 | ||||
IGLL1 | ENST00000438703.1 | c.261dupG | p.Phe88ValfsTer6 | frameshift_variant | Exon 2 of 3 | 2 | ENSP00000403391.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461860Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727232
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.